TTrialPathMatch Me to Trials
← Back to trials
RecruitingAcute Ischemic Stroke

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Eligible age

18–85 yrs

Accepts

All genders

Locations

6 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

SELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving better functional outcomes (measured using modified Rankin Scale Scores) at 90-day follow-up (± 15 days).

Sponsor: Amrou Sarraj

You may qualify if…

  • General Inclusion Criteria:
  • Adults (18-85\* years) with the final diagnosis of an acute ischemic stroke$
  • NIHSS ≥ 6
  • Time from last-known-well to randomization \>24 - 72 hours
  • Pre-stroke modified Rankin Scale score of 0-1
  • Eligible for thrombectomy and medical management
  • Signed Informed Consent obtained
  • Subject willing to comply with the protocol follow-up requirements

Where it's recruiting

Illinois

Chicago

Kansas

Kansas City

Missouri

St Louis

Rhode Island

Providence

Texas

Dallas

West Virginia

Morgantown

Source: ClinicalTrials.gov · NCT07115940 · last updated 2026-07-06

Medical Management With Endovascular Thrombectomy Versus Medical Manag · TrialPath